University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression of age-related macular degeneration, a leading cause of blindness in ...

The European Medicines Agency (EMA) has announced its approval of two new biosimilar medications, Afqlir and Opuviz, to treat age-related macular degeneration (ARMD). The active ingredient of both ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. More specifically, this ...

Age-related macular degeneration (AMD) remains a major cause of vision loss in ageing populations worldwide. Recent investigations have increasingly focussed on the therapeutic potential of ...

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the retina of mouse models. Neovascularization is a condition that is caused by age ...

Pachydrusen-associated AMD may progress slower than typical AMD. Age and macular pigment changes increase the risk of complications. Current AMD risk models may not apply to eyes with pachydrusen. AMD ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye, and it marks the first of a three-part series on dry ...

Previous studies on the protective benefits of metformin in AMD have produced mixed results. In this study, patients prescribed metformin had a similar risk of AMD development and progression compared ...

Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their risk of developing neovascular age-related macular degeneration (nAMD), ...

It's an unfortunate fact of aging: Live long enough and, eventually, reading this sentence will get difficult, even impossible. Three in 10 Americans older than 80 have some form of age-related ...

Neovascular age-related macular degeneration (nAMD) is a progressive eye disease characterized by choroidal neovascularization and subretinal hemorrhage and exudation, leading to vision impairment.